Daniel Howard

A market set to triple, driven by gene-level therapies, promises a revolution for children with rare epilepsies. But can our systems deliver this hope?

IncQuery's new AI tools promise to fuse speed with rigor, embedding an AI moderator directly into the secure workflows of consulting and private equity.

DuPont now powers its US healthcare plants with 100% renewables, a key move in a carbon-heavy sector. But a look behind the certificates reveals a complex strategy.

Inclusion in the Russell Microcap® Index is a milestone, but the real story is how the firm is engineering growth in the booming digital-first media landscape.

A silent disease affects 54 million Americans and is set to cost $95 billion by 2030. Now, 33 states are taking action against the osteoporosis epidemic.

While state budgets struggle, a local credit union is funding classroom innovation from the ground up, proving small investments can rebuild our educational systems.

AI platform FINNY's new enterprise deal with wealth giant Mercer Advisors reveals the industry's new playbook: using centralized tech to scale client acquisition.

With rental fraud costing hundreds of millions, PropTech firm 100 acquires a fintech-grade AI platform, signaling a new, systematic arms race to secure the housing market.

With three key leadership appointments, Las Vegas-based GenuBank is signaling a calculated push for growth, leveraging deep local ties and national experience.

A new report on 10 million vehicle shipments reveals a transformed industry. Cars are moving further, payments are faster, but a surge in sophisticated fraud looms.

A major refinancing deal for a prime London office tower reveals a new reality: sustainability is no longer a bonus, but a core driver of financial value.

An aging world and failing antibiotics are driving a surge in pneumonia. Now, a new generation of therapies is being built to fight back. Here's how.

A new generation of men is shattering the stigma around mental health at work, but a startling retention gap reveals a deeper crisis for employers.

A new documentary on a Silicon Valley engineer turned cricket hero reveals a calculated strategy: to win America's heart, you must first tell its stories.

As outdoor recreation booms, volunteer Search & Rescue teams are stretched thin. A unique corporate pledge offers a sustainable model to fund these vital services.

Septerna's novel oral drug for hypoparathyroidism could end the tyranny of injections and supplements, but its success hinges on a bigger bet: a new system for drugging life's most difficult molecular targets.

BestFarewell's appointment of Rianka Dorsainvil isn't just a hire; it's a signal. A look at how AI and human expertise are converging in a new system for legacy.

As GLP-1 drugs dominate, a UK biotech reveals a new drug that targets mitochondria, promising superior fat loss while preserving precious muscle mass.

A small biotech just unveiled data for an oral weight-loss pill that appears twice as effective as a key competitor in early tests, shaking up the market.

Sunseeker Elite's award-winning robots signal a major shift in home automation, using advanced AI and LiDAR to ditch boundary wires for good.